Kepos Capital LP 13D and 13G filings for Virpax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-26 4:05 pm Sale | 2022-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | Kepos Capital LP | 0 0.000% | -3,000 (Position Closed) | Filing |
| 2022-02-04 08:18 am Purchase | 2021-12-31 | 13G | Virpax Pharmaceuticals, Inc. VRPX | Kepos Capital LP | 3,000 6.400% | 3,000 (New Position) | Filing |